Erschienen in:
16.05.2018 | Invited Review
Follow-up after curative treatment of localised renal cell carcinoma
verfasst von:
Saeed Dabestani, Lorenzo Marconi, Teele Kuusk, Axel Bex
Erschienen in:
World Journal of Urology
|
Ausgabe 12/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Patients with localised renal cell carcinoma (RCC) receiving curative surgery, either radical or partial nephrectomy, have been shown in contemporary studies to develop recurrence within 5 years in 20–30% of case. Therefore, post-operative follow-up (FU) imaging plays a crucial role in detecting recurrent or metastatic disease. A number of prognostic scores have been developed to predict risk of recurrence. This review summarises the current knowledge on established FU protocols and their limitations.
Methods
A non-systematic literature search was conducted using Medline. Furthermore, major guidelines [European Association of Urology (EAU), American Urological Association (AUA) and National Comprehensive Cancer Network (NCCN)] were reviewed and assessed.
Results
The EAU, AUA and NCCN post-operative follow-up guidelines differ in the frequency and type of imaging modalities recommended. The optimal duration of follow-up remains to be elucidated as does the impact of follow-up protocols on patient outcomes and quality of life. Established follow-up protocols do not take non-RCC-related factors, such as patient age and performance status into account. However, in the future individualised duration of FU based on competing risks of cancer recurrence and non-RCC death may be optimised, maximising resources and patient quality of life.
Conclusion
There is a clear need to establish evidence-based follow-up protocols and to assess the impact of follow-up protocols on individual patients and society.